Antifilarial
Diethylcarbamazine
Brand names: Hetrazan (specialist import)
Adult dose
Dose: 6mg/kg/day PO in divided doses for 12–21 days (per indication and weight-based titration)
Route: Oral
Frequency: OD–TDS
Clinical pearls
- Lymphatic filariasis (Wuchereria bancrofti), Loa loa
- WHO neglected tropical disease guidance
- UKHSA imported infection / National Travel Health Network
- Specialist tropical medicine prescribing; obtain via specialist import
Contraindications
- Concurrent or untreated onchocerciasis (severe Mazzotti reaction; treat with ivermectin first)
- Concurrent loiasis with high microfilarial load (encephalopathy risk)
- Pregnancy
- Hypersensitivity
Side effects
- Mazzotti reaction (fever, rash, lymphadenopathy from microfilarial death)
- Encephalopathy (loiasis)
- Headache
- GI upset
Interactions
- Alcohol (Antabuse-like reaction)
Monitoring
- Symptoms / CNS
- Microfilarial load
- FBC
Reference: BNF; WHO NTD guidelines; UKHSA imported infections; https://bnf.nice.org.uk/drugs/diethylcarbamazine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023